Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Biocytogen and Acepodia Partner to Develop Dual-Payload Bispecific ADCs for Oncology
CompanyDeals

Biocytogen and Acepodia Partner to Develop Dual-Payload Bispecific ADCs for Oncology

January 9, 2025
Sanofi's Sarclisa Gains NMPA Approval for Multiple Myeloma Treatment in China
CompanyDrug

Sanofi’s Sarclisa Gains NMPA Approval for Multiple Myeloma Treatment in China

January 9, 2025
Araris Biotech and Chugai Pharmaceutical Collaborate on Novel ADC Development
CompanyDeals

Araris Biotech and Chugai Pharmaceutical Collaborate on Novel ADC Development

January 9, 2025
Mirror Biologics and Merck KGaA Collaborate on Phase II Trial for Colorectal Cancer Immunotherapy
CompanyDeals

Mirror Biologics and Merck KGaA Collaborate on Phase II Trial for Colorectal Cancer Immunotherapy

January 9, 2025
Johnson & Johnson's Posdinemab Receives FDA Fast Track Designation for Alzheimer’s Disease
CompanyDrug

Johnson & Johnson’s Posdinemab Receives FDA Fast Track Designation for Alzheimer’s Disease

January 9, 2025
Boston Scientific Set to Acquire Bolt Medical for Up to USD 900 Million
CompanyDeals

Boston Scientific Set to Acquire Bolt Medical for Up to USD 900 Million

January 9, 2025
China's Central Committee and State Council Outline Reforms for Elderly Care Services
CompanyPolicy / Regulatory

China’s Central Committee and State Council Outline Reforms for Elderly Care Services

January 9, 2025
Xtalpi's Ailux Biologics Partners with UCB for AI-Driven Drug Discovery
CompanyDeals

Xtalpi’s Ailux Biologics Partners with UCB for AI-Driven Drug Discovery

January 9, 2025
Shanghai Opens Door to Wholly Foreign-Owned Hospitals in Key Areas
Policy / Regulatory

Shanghai Opens Door to Wholly Foreign-Owned Hospitals in Key Areas

January 9, 2025
NHSA Strengthens Medical Security Rights for Workers in China
Policy / Regulatory

NHSA Strengthens Medical Security Rights for Workers in China

January 9, 2025
CompanyDeals

Duality Biologics and Avenzo Ink Exclusive License for DB-1418/AVZO-1418

March 3, 2025
MSD's Gardasil Vaccine Gains NMPA Approval for Use in Males Aged 9 to 26
CompanyDrug

MSD’s Gardasil Vaccine Gains NMPA Approval for Use in Males Aged 9 to 26

January 8, 2025
1 2 … 280 281 282 283 284 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up